LAPLACE-TIMI 57: Low-density Lipoprotein Cholesterol (LDL-C) Assessment With PCSK9 monoclonaL Antibody Inhibition Combined With Statin thErapy

PHASE2CompletedINTERVENTIONAL
Enrollment

631

Participants

Timeline

Start Date

July 1, 2011

Primary Completion Date

April 5, 2012

Study Completion Date

April 5, 2012

Conditions
Hyperlipidemia
Interventions
BIOLOGICAL

Evolocumab

Administered by subcutaneous injection

OTHER

Placebo to Evolocumab

Administered by subcutaneous injection

Trial Locations (100)

1096

Research Site, Budapest

2400

Research Site, Dunaújváros

2750

Research Site, Ballerup Municipality

2991

Research Site, Komárom

3300

Research Site, Eger

4032

Research Site, Debrecen

5004

Research Site, Szolnok

5700

Research Site, Gyula

6000

Research Site, Kecskemét

7100

Research Site, Vejle

8900

Research Site, Zalaegerszeg

9000

Research Site, Aalborg

9200

Research Site, Mosonmagyaróvár

10567

Research Site, Cortlandt Manor

14221

Research Site, Williamsville

15216

Research Site, Pittsburgh

17011

Research Site, Camp Hill

17405

Research Site, York

19104

Research Site, Philadelphia

27103

Research Site, Winston-Salem

27577

Research Site, Smithfield

29302

Research Site, Spartanburg

29501

Research Site, Florence

32043

Research Site, Green Cove Springs

32117

Research Site, Daytona Beach

32901

Research Site, Melbourne

33143

Research Site, Miami

33173

Research Site, Miami

33952

Research Site, Port Charlotte

35294

Research Site, Birmingham

38301

Research Site, Jackson

38305

Research Site, Jackson

38801

Research Site, Tupelo

40536

Research Site, Lexington

43302

Research Site, Marion

44708

Research Site, Canton

44870

Research Site, Sandusky

44906

Research Site, Mansfield

45212

Research Site, Cincinnati

45219

Research Site, Cincinnati

45414

Research Site, Dayton

46237

Research Site, Indianapolis

46320

Research Site, Hammond

46383

Research Site, Valparaiso

48197

Research Site, Ypsilanti

49048

Research Site, Kalamazoo

49855

Research Site, Marquette

52242

Research Site, Iowa City

53713

Research Site, Madison

57701

Research Site, Rapid City

59405

Research Site, Great Falls

61614

Research Site, Peoria

72104

Research Site, Malvern

77002

Research Site, Houston

77074

Research Site, Houston

80120

Research Site, Littleton

80909

Research Site, Colorado Springs

85710

Research Site, Tucson

91361

Research Site, Westlake Village

92663

Research Site, Newport Beach

92801

Research Site, Anaheim

95608

Research Site, Carmichael

95747

Research Site, Roseville

98405

Research Site, Tacoma

04210

Research Site, Auburn

04401

Research Site, Bangor

04101

Research Site, Portland

08043

Research Site, Voorhees Township

V5G 1T4

Research Site, Burnaby

V1Y 1V6

Research Site, Kelowna

V6Z 1Y6

Research Site, Vancouver

V8T 5G1

Research Site, Victoria

N1R 6V6

Research Site, Cambridge

P3C 5K7

Research Site, Greater Sudbury

L8L 2X2

Research Site, Hamilton

N5W 6A2

Research Site, London

N6A 5K8

Research Site, London

L3Y 5G8

Research Site, Newmarket

L1J 2J9

Research Site, Oshawa

L1J 2K1

Research Site, Oshawa

N7T 4X3

Research Site, Sarnia

M1P 2T7

Research Site, Scarborough Village

M8V 3X8

Research Site, Toronto

M9V 4B4

Research Site, Toronto

N4S 5P5

Research Site, Woodstock

J8Y 6S9

Research Site, Gatineau

H8S 2E4

Research Site, Lachine

J4N 0C9

Research Site, Longueuil

H9R 3J1

Research Site, Pointe-Claire

G1V 4M6

Research Site, Québec

603 00

Research Site, Brno

625 00

Research Site, Brno

656 91

Research Site, Brno

775 20

Research Site, Olomouc

120 00

Research Site, Prague

140 21

Research Site, Prague

274 01

Research Site, Slaný

568 25

Research Site, Svitavy

562 18

Research Site, Ústí nad Orlicí

669 02

Research Site, Znojmo

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

The TIMI Study Group

OTHER

lead

Amgen

INDUSTRY

NCT01380730 - LAPLACE-TIMI 57: Low-density Lipoprotein Cholesterol (LDL-C) Assessment With PCSK9 monoclonaL Antibody Inhibition Combined With Statin thErapy | Biotech Hunter | Biotech Hunter